# The Protection Effect of Speeda® Rabies Vaccine for Human Use

> **NCT01827917** · PHASE4 · COMPLETED · sponsor: **Beijing Center for Disease Control and Prevention** · enrollment: 37 (actual)

## Conditions studied

- Rabies Vaccine Allergy

## Interventions

- **BIOLOGICAL:** rabies vaccine

## Key facts

- **NCT ID:** NCT01827917
- **Lead sponsor:** Beijing Center for Disease Control and Prevention
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2016-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01827917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01827917, "The Protection Effect of Speeda® Rabies Vaccine for Human Use". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01827917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*